In development and differentiation, morphological changes often accompany mechanical changes [1] , but it is unclear whether or when cells in embryos sense tissue elasticity. The earliest embryo is uniformly pliable, while adult tissues vary widely in mechanics from soft brain and stiff heart to rigid bone [2] . However, cell sensitivity to microenvironment elasticity is debated based in part on results from complex three-dimensional culture models [3] . Regenerative cardiology provides strong motivation to clarify any cell-level sensitivities to tissue elasticity because rigid postinfarct regions limit pumping by the adult heart [4] . Here, we focus on the spontaneously beating embryonic heart and sparsely cultured cardiomyocytes, including cells derived from pluripotent stem cells. Tissue elasticity, E t , increases daily for heart to 1-2 kPa by embryonic day 4 (E4), and although this is w10-fold softer than adult heart, the beating contractions of E4 cardiomyocytes prove optimal at wE t,E4 both in vivo and in vitro. Proteomics reveals daily increases in a small subset of proteins, namely collagen plus cardiacspecific excitation-contraction proteins. Rapid softening of the heart's matrix with collagenase or stiffening it with enzymatic crosslinking suppresses beating. Sparsely cultured E4 cardiomyocytes on collagen-coated gels likewise show maximal contraction on matrices with native E4 stiffness, highlighting cell-intrinsic mechanosensitivity. While an optimal elasticity for striation proves consistent with the mathematics of force-driven sarcomere registration, contraction wave speed is linear in E t as theorized for excitation-contraction coupled to matrix elasticity. Pluripotent stem cell-derived cardiomyocytes also prove to be mechanosensitive to matrix and thus generalize the main observation that myosin II organization and contractile function are optimally matched to the load contributed by matrix elasticity.
Summary
In development and differentiation, morphological changes often accompany mechanical changes [1] , but it is unclear whether or when cells in embryos sense tissue elasticity. The earliest embryo is uniformly pliable, while adult tissues vary widely in mechanics from soft brain and stiff heart to rigid bone [2] . However, cell sensitivity to microenvironment elasticity is debated based in part on results from complex three-dimensional culture models [3] . Regenerative cardiology provides strong motivation to clarify any cell-level sensitivities to tissue elasticity because rigid postinfarct regions limit pumping by the adult heart [4] . Here, we focus on the spontaneously beating embryonic heart and sparsely cultured cardiomyocytes, including cells derived from pluripotent stem cells. Tissue elasticity, E t , increases daily for heart to 1-2 kPa by embryonic day 4 (E4), and although this is w10-fold softer than adult heart, the beating contractions of E4 cardiomyocytes prove optimal at wE t,E4 both in vivo and in vitro. Proteomics reveals daily increases in a small subset of proteins, namely collagen plus cardiacspecific excitation-contraction proteins. Rapid softening of the heart's matrix with collagenase or stiffening it with enzymatic crosslinking suppresses beating. Sparsely cultured E4 cardiomyocytes on collagen-coated gels likewise show maximal contraction on matrices with native E4 stiffness, highlighting cell-intrinsic mechanosensitivity. While an optimal elasticity for striation proves consistent with the mathematics of force-driven sarcomere registration, contraction wave speed is linear in E t as theorized for excitation-contraction coupled to matrix elasticity. Pluripotent stem cell-derived cardiomyocytes also prove to be mechanosensitive to matrix and thus generalize the main observation that myosin II organization and contractile function are optimally matched to the load contributed by matrix elasticity.
Results and Discussion
The heart is the first functional organ in vertebrate embryos. It beats spontaneously as a heart tube by w36 hr after fertilization ( Figure 1A ). Subsequent stiffening has been described thus far in terms of changes in cell volume, hyaluronic acid, and/or collagen I [5] , but functional evaluations of such changes have been lacking. Cardiomyocytes isolated from either late embryos [6, 7] or neonates [8] [9] [10] and cultured on substrates of varied stiffness suggest that gels that are stiffer than adult heart suppress contraction. Extremely soft substrates suppress sarcomere organization and limit contractile ability, with additional evidence of altered cytoskeletal conformation and assembly [6] in the absence of changes in mechanosensitive degradation [11] or transcription [12] that are evident in other cells. Mature cells cultured on gels can thus exhibit an optimal stiffness for contraction, but relevance of matrix elasticity to intact heart remains unclear and controversial based on a handful of culture studies (e.g., [3] ).
Heart Stiffens with Expression of Excitation-Contraction and Collagen Proteins, whereas Brain Remains Soft Tissue aspiration into micropipettes ( Figure 1B ) of diameter sufficient to probe dozens of cells plus extracellular matrix [1] shows that heart at all stages behaves elastically ( Figure 1C ), whereas midbrain tissue and embryonic disk flow over minutes and fail to recover fully after release of the applied stress. The effective Young's modulus of each tissue, E t , was calculated from the slope of aspiration pressure versus aspirated length (see Figure S1A available online) [13] , and for brain and embryonic disc, the (already large) aspirated length at 2 min was used. By E2, the presumptive ventricle is already 3-fold stiffer than undifferentiated embryonic disc and embryonic brain. The latter remains roughly constant through development at 0.3 6 0.2 kPa ( Figure 1D ) and matches adult brain stiffness [14] . Brain tissue is thus always soft, whereas heart stiffens up to about 10-fold to reach neonate and adult heart stiffness by wE14 [6] . Modest stiffness variations of 620% along the heart tube ( Figure S1B ) are also consistent with past reports [15] .
Expression trends for at least some tissue proteins seemed likely to parallel the divergent trends in tissue mechanics and to confer tissue stiffness. Quantitative mass spectrometry of extracts from embryonic discs and E2-E4 and E10 heart and brain tissue identified over 200 diverse proteins (Table S1) , of which fewer than 10% followed trends in expression similar to those of E t ( Figures 1D-1H , S1C, and S1D). Most trendfollowing proteins related closely to the excitation-contraction coupling system, such as cardiac actomyosin contractile proteins, adhesion proteins, and the sarcoplasmic calcium channel SERCA. Mitochondrial proteins (relevant to energetics) also followed the trends, but with smaller differences between heart and brain. Proteins that were notably uncorrelated with tissue stiffness included many nuclear proteins, intermediate filament proteins, and nonmuscle myosin. Of two extracellular matrix (ECM) proteins detected, fibronectin and collagen I, only collagen I follows the E t trends.
To begin to assess stiffness contributions of the actomyosin cytoskeleton or collagen, we inhibited myosin contractility with the myosin II ATPase inhibitor blebbistatin or else disrupted the collagenous ECM with mild collagenase treatments and then measured tissue stiffness. With blebbistatin, heart tissue from E2 to E14 is softened by w25% and brain tissue by w50% ( Figure S1E ). In contrast, collagenase had no significant effect on brain tissue but considerably softened both *Correspondence: discher@seas.upenn.edu early and late heart ( Figure S1F ), without perturbing myosin II levels ( Figure S1G ). The stiffness of brain tissue thus seems cellular in nature, whereas heart tissue mechanics have major extracellular matrix contributions at even the earliest functional stage of beating.
Modest Softening or Stiffening Impairs Beating
Embryonic heart tubes beat spontaneously at w1 Hz for up to 1-2 days after isolation, and we could easily measure local tissue strain in heart tubes during beating by imaging GFP-transfected cells as fiducial markers (Figure 2A ). This very visible activity is used to address the main question of our studies: whether cells in an intact living tissue are sensitive to microenvironment elasticity. Controlled dose-time treatments with collagenase provided a simple means of softening tissue matrix (in only 30 min), while enzymatic crosslinking of ECM with transglutaminase provided a similarly rapid method to stiffen tissue ( Figures S2A and S2B) . Enzyme permeated the tissue ( Figure S2C ), and for all but the most extreme softening treatment, embryonic heart behaved elastically in micropipette aspiration ( Figure S2B, inset) . By transfecting cells with a GFP membrane protein (SIRPA-GFP), we could also see that the contours of beating cells were unaffected by collagenase ( Figures 2B and S2D ). Tissue softening is thus due primarily to cleavage of ECM rather than disruption of cell connections. (A) E3 chick embryo with heart tube (white box) and midbrain (blue box) in situ and after isolation. The heart continues to beat ex vivo, with contraction and flow propagating along the dashed line. Scale bar represents 100 mm.
(B) Micropipette aspiration of an E3 heart tube in phase-contrast microscopy using pipettes that are much larger in diameter than single cells. Scale bar represents 10 mm.
(C) Representative aspiration and relaxation curves for E4 heart and brain demonstrate the respective elastic and inelastic responses. (D) E t for heart and brain tissue throughout embryonic development, starting with day 1 embryonic disk, then E2, E4, E6, and E14 heart and brain (n R 3 measurements each). By the time beating starts, the heart is already 3-fold stiffer than early embryonic tissue and then stiffens at a rate of 0.3 kPa/day. Due to the thick epicardium of E6 and older hearts relative to the inner diameter of our micropipettes, measurements likely underestimate stiffness of the myocardium at those stages due to significant contribution of epicardium. Brain tissue does not stiffen during development and remains viscoelastic with a mean E t = 0.3 kPa.
(E) Quantitative mass spectrometry (MS) of cellular proteins extracted from intact embryonic disc (Hamburger-Hamilton stages 3-4), E2, E3, E4, and E10 heart and brain tissue reveals a small set of detected proteins with expression patterns similar to heart or brain mechanics: namely, a general increase in heart and relatively small increase in brain. Expression is relative to average in brain E2-E3 (n R 3 MS measurements).
(F) Immunoblot confirms that MS measurements of cardiac myosin II expression increase in heart development. Samples are pooled from three to four embryos at each reported stage and were normalized to lamin-B1 (n R 3).
(G) MS indicates that collagen I expression increases during heart development, but not greatly during brain development. Inset images: 1% SDS-decellularized E4 and E14 hearts. The insoluble matrices retain the shape of the embryonic hearts, but whereas E14 matrix (with 80% of MS ion current being collagen I) appears solid, the E4 matrix appears more reticulated and porous, consistent with relatively less mass. (H) Of the proteins identified by MS (Table S1 ), a small subset had expression levels across tissues and development that paralleled mechanics. Error bars in all figures represent SEM.
After the enzymatic treatments, hearts continue to beat rhythmically (Movie S1), but the magnitude of local contraction (calculated from GFP-expressing cells) was always affected. Each heart tube region was analyzed separately ( Figures  S2E-S2I) , and normalization to pretreatment measurements accounted for slight variations (w20%) in embryo age and/or lab temperature. Untreated tissue invariably showed the largest contraction, which was typically w10% strain, while both softening and stiffening of the heart suppressed contractile strain ( Figures 2C and S2E ). Stiffening of tissue should suppress strain because any muscle cell has a finite capacity to work against a very high load, but softening of the tissue matrix also decreased contractile strain. Consistent with these E4 results, softening of E6 hearts likewise impeded beating ( Figure 2D) . A mathematical theory for striation [17] provides a basis for modeling contractile functions with the equation
which also fits contractile strains in experiments ( Figure 2C , dashed line; Box S1). The optimal stiffness for heart contraction is thus the stiffness of native heart. The speed of the contraction wave in each heart region increases monotonically with tissue stiffness, except for the most extreme rigidity ( Figure 2E ). The linearity of wave speed can be predicted from a viscoelastic model of active media (Box S2). For the rigidified heart, beating was still evident, but the contraction wave did not propagate past the pacemaker region in the atrium ( Figure S2I ). Softening treatments also decreased the probability of contractions propagating out of the atrium.
E4 and Stem Cell-Derived Cardiomyocytes Are Highly Sensitive to Matrix Elasticity
To assess whether variations in matrix elasticity affect E4-cardiomyocyte adhesion and beating, isolated cells and their properties were studied as sparse cultures on collagen I-coated polyacrylamide gels of varied stiffness ( Figure 3A) . Most of the cultured cells beat at 0.5-1.5 Hz, similar to the heart, indicating high viability as well as sustained adhesion. Relaxed morphologies were measured after 24 hr in culture and showed that substrates stiffer than E4 heart tissue promote spreading and elongation ( Figure S3A) , as is common with other mesenchymal cell types (e.g., [12] ). Cells on matrices of stiffness similar to that of the tissue of origin (w1-2 kPa) were relatively round and unspread compared to the maximum achievable elongation and spreading. Nonetheless, contractile deformation of an E4 cardiomyocyte and its local matrix proves optimal at the matrix elasticity of native E4 tissue ( Figure 3B ). In vitro contractions were measured in terms of both 2D strains using cell edge displacements and changes in aspect ratio.
Cardiomyocytes derived from embryonic stem cells (ESC-CM), induced pluripotent stem cells (iPS-CM), or directly transdifferentiated cells hold great potential for regenerative therapies [18] , and human ESC-CM and iPS-CM displace (B) SIRPA-GFP-expressing cell in transfected E4 heart tissue before and after softening. Overlays of SIRPA-GFP-expressing cells over time help visualize cell shape changes during contraction and softening treatments. Overlay of the same cell pretreatment while relaxed (green) and contracted (red) (bottom left) shows less overlap (yellow) than the relaxed cell before and after tissue softening; cells thus maintain morphology and adhesions during softening. (C) Tissue strain during beating of GFP-transfected softened and stiffened E4 heart normalized to that of untreated and the resulting relative strain averaged for atria, ventricles, and outflow tract: softened and stiffened tissues suppress contractions. Typical peak strains throughout the untreated heart tube were 10% 6 4%. The dashed curve is a fit to Equation 1 with exponent n = 4 6 1 and E m = 1.6 6 0.2 kPa. (D) E6 hearts treated progressively with collagenase stop beating or beat only partially. Beating is suppressed after 50 min softening treatment, relative to untreated or briefly (10-30 min) treated hearts (p = 0.016). Insets: representative aspiration-relaxation curves for mildly softened or considerably softened hearts. Red indicates untreated tissue; blue indicates treated tissue. (E) Velocity of the contraction wave through the ventricle versus normalized E t . Wave speeds in untreated ventricle, atria, and outflow tract of 22 6 4, 4 6 2, and 2.8 6 0.7 mm/s, respectively, are consistent with past work [16] . For the most extreme stiffening treatment, contraction does not propagate past the presumptive pacemaker. The dashed line is the theoretical prediction with a single adjustable parameter, namely the ratio of the stress threshold to the magnitude of the force dipole corresponding to a contracting cell. E o indicates the theoretically predicted stiffness below which a contraction wave should not propagate. Error bars for all figures represent SEM (n R 3 hearts).
soft matrix more than stiffer matrix [19] . Here, ESC-CM on soft, intermediate, and stiff substrates that match immature (1 kPa), mature (11 kPa), and diseased (34 kPa) myocardium express at day 4 in culture similar levels of sarcomeric proteins, but myofibril organization is visibly optimal for intermediate stiffness, and contracting edge velocities decrease with substrate stiffness (Figures S3B-S3E ). On soft substrates in day 6 cultures, myofibrils decrease and beating stops, whereas ESC-CM on the intermediate and stiff substrates bifurcated into either fast or slow contracting cell populations. Cardiogenesis is thus generally sensitive to matrix mechanics. (B) Edge strain of cardiomyocytes cultured on PA gels of various stiffnesses, measured as the trace of the 2D strain matrix of cell edge points during beating, as described in Supplemental Experimental Procedures. In beating, cell and matrix strain are strongly modulated by substrate elasticity with an optimal E gel similar to that of E4 heart and much lower than that measured for more mature cells ( [6, 8] ). Softer and stiffer substrates impede beating of cultured cells. The Lorentzian fit gives E m = 1.3 6 0.3 kPa, consistent with the tissue elasticity of E4 hearts (E t = 1.3 6 0.4 kPa in Figure 1 ). (C and D) Representative image of E7 cardiomyocytes recovering from latrunculin A (Lat-A) treatment in the presence (C) or absence (D) of blebbistatin, which does not affect cell viability [12] . (E) Myofibril assembly was measured as the percentage of cell area covered by mature myofibrils (sarcomere spacing > 1.5 mm). Inhibition of beating and actomyosin contractility by blebbistatin reduces the amount of new myofibrils formed following Lat-A washout and causes mature myofibrils to disassemble per (C). Inset shows that for these late embryo cardiomyocytes, the optimal elasticity for rapid recovery of striated premyofibrils is close to that of adult heart (E t w 10-15 kPa). Error bars are SEM (n R 3 cells). *p < 0.05. striation proteins are mobile on timescales of 1-10 min [20] . Cardiomyocytes treated with the myosin II ATPase inhibitor blebbistatin do not beat even though calcium transients are unaffected [21] , and cells beat again within seconds after drug washout [22] . This is far quicker than contractility responses to heart matrix alterations in the 0.5-2 hr treatments here. To assess a role for myosin II activity and contractile forces in striation as assumed in the modeling here [17] (Box S1), we grew E7 cells with abundant striation on gels optimal for striation [6] , pulsed them for 30 min with latrunculin to disassemble myofibrils, and then added blebbistatin to half of the cultures (Figures 3C and  3D ). In the absence of blebbistatin, both premyofibrils and mature myofibrils recovered over a few hours from the induced disassembly, and most cells were filled with striations after 24 hr (Figures 3D and 3E) , whereas sustained blebbistatin suppressed striation, consistent with striation requiring active myosin II.
Optimal Striation Depends on Myosin II Contractile Activity

Myofibril Order Depends on Matrix Elasticity
With E4 hearts, we sought to quantify any possible striation differences with and without matrix alterations. Sarcomeric a-actinin-2 is a key crosslinker of ''z bands'' that is seen in mature myofibrils within embryos and also in shorter-period premyofibrils using deconvolution microscopy [23] . In our confocal imaging, we measured sarcomere spacing lateral ''breadth'' of z bands along in-plane sarcomeres as a key metric of registry ( Figure 4A, inset) . Whereas striation spacing peaked at 1.8 mm and appeared unaffected by w50% softening of the E4 heart, z band breadth was reduced relative to untreated control ( Figure 4B ). This decreased registry of myofibrils shortly after softening of the matrix indicates a decreased coupling of sarcomeres and is consistent with the striation model [17] , highlighting a molecular-scale mechanism for decreased contraction against decreased extracellular load.
Isolated cardiomyocytes beating on gels ( Figure 4C ) show striation spacing of w1 mm for premyofibrils, which conforms to expectations [20] , and also the typical w1.9 mm spacing of myofibrils ( Figure 4D ) evident in intact heart. Striation spacing shows no variation with matrix, but the abundance of myofibrils relative to premyofibrils is maximized on matrices of elasticity 2-10 kPa ( Figure 4E ). This is consistent with myofibril assembly from premyofibrils [20] . The z band breadth of myofibrils also exhibited a broad and significant (p < 0.05) maximum (at w2 mm breadth) within a similar range of matrix elasticities that promote myofibril formation ( Figure 4F) . The premyofibrils exhibited a somewhat narrower (w1.5 mm) z band breadth that decreased on the stiffest substrates. Myofibril structural trends in response to substrate stiffness in culture are thus consistent with intact E4 heart and suggest a common mechanism of stiffness-dependent registration. z band breadth results for both mature myofibrils and premyofibrils ( Figure 4F) were also fit by Equation 1 with respective E m = 4.2 6 0.6 and 1.7 6 0.3 kPa (n = 0.24 6 0.1). Differences in E m suggest that myofibril organization favors a stiffer matrix or higher load. However, z band breadth also likely underestimates registration order within a cell, as it only includes immediately adjacent and perfectly registered striated fibers. Indeed, z band breadth trends for myofibrils and premyofibrils in isolated cells are broader than in simulation [17] but are still consistent with trends for intact heart ( Figures 4B and 4F) . What emerges systematically from fitting to Equation 1 is that n increases with length scale: the smallest n is determined for z band breadth in culture, and the largest n is found for strain in the intact heart. High cell density, 3D cell-matrix coupling, and cell-cell signaling in tissue (including calcium excitation waves) could all provide a basis for the enhanced sensitivity to matrix E of tissue.
Protein interactions that govern molecular mobility are force sensitive in living cardiomyocytes and vary with matrix elasticity [6] . An optimum stiffness for striation is thus understandable: while contractile activity ''massages'' registration ( Figures 3E and 4) and these forces increase with matrix stiffness [1] , high forces on stiff matrix tend to break bonds [6] . Myofibrils thereby misregister if the load is either too low or high, which largely explains why parallel and optimal increases in actomyosin proteins and collagens (Figure 1 ) must be coordinated in the tissue development program. Invading and proliferating fibroblasts make and remodel the matrix that stimulates cardiomyocyte proliferation [24] with increased expression of specialized contractile proteins (a-actinin-2, cardiac myosin II in Figures 1D and 1E) , and so it is sensible that this program requires matrix engagement by integrins [24] and extends to mechanosensitive, adhesion complex proteins such as talin [25] that also increase ( Figure 1D) . Moreover, since collagen synthesis and organization by fibroblasts are regulated by strain (as reviewed in [26] ), heart matrix is likely to be optimized by the optimal stiffness for cardiomyocyte striation and contraction (Figures 2, 3, and 4) . The fact that the optimum increases in development from 1 to 2 kPa at E4 toward the stiffness of adult heart (e.g., Figures 1C and  3E , inset) [6, 8, 9 ] is also consistent with preliminary observations that hearts that were stiffened and stopped beating would sometimes restart their beating 10 hr later. Last, excitation-contraction coupling (ECC) in muscle physiology is well established [27] , but the broad effects of matrix stiffness on individual cells in sparse culture preclude the confounding impacts of cell-cell electrical communication and ultimately suggest that excitation-contraction-matrix coupling (ECMC) is required to truly understand muscle.
Experimental Procedures
Heart isolation (per IACUC-approved protocol 804455), enzyme treatments, micropipette analyses, tissue strain analyses, mass spectrometry proteomics, cell isolation, and standard techniques are described in detail in the Supplemental Experimental Procedures.
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